Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Udonitrectag in Moderate to Severe Neurotrophic Keratitis
NCT04276558Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Oct 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules, Modified Peptides
- Countries
- 7
01
Overview
A Phase 2 trial of udonitrectag in neurotrophic keratitis (NK), sponsored by Recordati SpA. Started Oct 2020; status: completed.
02
Drugs
udonitrectag
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT04276558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04276558.